Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SRx Health Solutions (SRXH) Consolidated Net Income: 2010-2025

Historic Consolidated Net Income for SRx Health Solutions (SRXH) over the last 16 years, with Q2 2025 value amounting to -$16.8 million.

  • SRx Health Solutions' Consolidated Net Income fell 52783.58% to -$16.8 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$9.3 million, marking a year-over-year increase of 5030.79%. This contributed to the annual value of $4.2 million for FY2024, which is 11841.02% up from last year.
  • Per SRx Health Solutions' latest filing, its Consolidated Net Income stood at -$16.8 million for Q2 2025, which was down 52783.58% from -$964000.0 recorded in Q1 2025.
  • Over the past 5 years, SRx Health Solutions' Consolidated Net Income peaked at $24.8 million during Q2 2021, and registered a low of -$24.4 million during Q4 2022.
  • In the last 5 years, SRx Health Solutions' Consolidated Net Income had a median value of -$3.5 million in 2021 and averaged -$4.0 million.
  • Per our database at Business Quant, SRx Health Solutions' Consolidated Net Income skyrocketed by 29820.8% in 2021 and then tumbled by 52783.58% in 2025.
  • SRx Health Solutions' Consolidated Net Income (Quarter) stood at -$5.1 million in 2021, then crashed by 379.28% to -$24.4 million in 2022, then soared by 39.7% to -$14.7 million in 2023, then skyrocketed by 157.93% to $8.5 million in 2024, then crashed by 297.72% to -$16.8 million in 2025.
  • Its Consolidated Net Income stands at -$16.8 million for Q2 2025, versus -$964000.0 for Q1 2025 and $8.5 million for Q4 2024.